Company / Shareholders' Equity
Glucotrack, Inc. Shareholders' Equity History
FY2014-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
-$1.4M
FY2020
5-year range
-$16.6M / -$1.4M
FY2016-FY2020
Trend
+50.9%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Glucotrack, Inc. reports negative total equity of -$1M in FY2020. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-$1M in FY2020.
Improved from -$17M to -$1M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2020, shareholders' equity increased 50.9% year-over-year.
- Peak shareholders' equity was recorded in FY2014.
- Lowest shareholders' equity in the period was in FY2018.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | -$1.4M | +50.9% |
| FY2019 | -$2.9M | +82.7% |
| FY2018 | -$16.6M | -51.4% |
| FY2017 | -$10.9M | -126.6% |
| FY2016 | -$4.8M | +56.3% |
| FY2015 | -$11.1M | -2099.1% |
| FY2014 | -$503.1K | - |
As of FY2020 · SEC 10-K · Updated Jun 24, 2026